Cargando…
Intracoronary Administration of Allogeneic Adipose Tissue–Derived Mesenchymal Stem Cells Improves Myocardial Perfusion But Not Left Ventricle Function, in a Translational Model of Acute Myocardial Infarction
BACKGROUND: Autologous adipose tissue–derived mesenchymal stem cells (ATMSCs) therapy is a promising strategy to improve post–myocardial infarction outcomes. In a porcine model of acute myocardial infarction, we studied the long‐term effects and the mechanisms involved in allogeneic ATMSCs administr...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524109/ https://www.ncbi.nlm.nih.gov/pubmed/28468789 http://dx.doi.org/10.1161/JAHA.117.005771 |
_version_ | 1783252422846578688 |
---|---|
author | Bobi, Joaquim Solanes, Núria Fernández‐Jiménez, Rodrigo Galán‐Arriola, Carlos Dantas, Ana Paula Fernández‐Friera, Leticia Gálvez‐Montón, Carolina Rigol‐Monzó, Elisabet Agüero, Jaume Ramírez, José Roqué, Mercè Bayés‐Genís, Antoni Sánchez‐González, Javier García‐Álvarez, Ana Sabaté, Manel Roura, Santiago Ibáñez, Borja Rigol, Montserrat |
author_facet | Bobi, Joaquim Solanes, Núria Fernández‐Jiménez, Rodrigo Galán‐Arriola, Carlos Dantas, Ana Paula Fernández‐Friera, Leticia Gálvez‐Montón, Carolina Rigol‐Monzó, Elisabet Agüero, Jaume Ramírez, José Roqué, Mercè Bayés‐Genís, Antoni Sánchez‐González, Javier García‐Álvarez, Ana Sabaté, Manel Roura, Santiago Ibáñez, Borja Rigol, Montserrat |
author_sort | Bobi, Joaquim |
collection | PubMed |
description | BACKGROUND: Autologous adipose tissue–derived mesenchymal stem cells (ATMSCs) therapy is a promising strategy to improve post–myocardial infarction outcomes. In a porcine model of acute myocardial infarction, we studied the long‐term effects and the mechanisms involved in allogeneic ATMSCs administration on myocardial performance. METHODS AND RESULTS: Thirty‐eight pigs underwent 50 minutes of coronary occlusion; the study was completed in 33 pigs. After reperfusion, allogeneic ATMSCs or culture medium (vehicle) were intracoronarily administered. Follow‐ups were performed at short (2 days after acute myocardial infarction vehicle‐treated, n=10; ATMSCs‐treated, n=9) or long term (60 days after acute myocardial infarction vehicle‐treated, n=7; ATMSCs‐treated, n=7). At short term, infarcted myocardium analysis showed reduced apoptosis in the ATMSCs‐treated animals (48.6±6% versus 55.9±5.7% in vehicle; P=0.017); enhancement of the reparative process with up‐regulated vascular endothelial growth factor, granulocyte macrophage colony‐stimulating factor, and stromal‐derived factor‐1α gene expression; and increased M2 macrophages (67.2±10% versus 54.7±10.2% in vehicle; P=0.016). In long‐term groups, increase in myocardial perfusion at the anterior infarct border was observed both on day‐7 and day‐60 cardiac magnetic resonance studies in ATMSCs‐treated animals, compared to vehicle (87.9±28.7 versus 57.4±17.7 mL/min per gram at 7 days; P=0.034 and 99±22.6 versus 43.3±14.7 22.6 mL/min per gram at 60 days; P=0.0001, respectively). At day 60, higher vascular density was detected at the border zone in the ATMSCs‐treated animals (118±18 versus 92.4±24.3 vessels/mm(2) in vehicle; P=0.045). Cardiac magnetic resonance–measured left ventricular ejection fraction of left ventricular volumes was not different between groups at any time point. CONCLUSIONS: In this porcine acute myocardial infarction model, allogeneic ATMSCs‐based therapy was associated with increased cardioprotective and reparative mechanisms and with better cardiac magnetic resonance–measured perfusion. No effect on left ventricular volumes or ejection fraction was observed. |
format | Online Article Text |
id | pubmed-5524109 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-55241092017-08-02 Intracoronary Administration of Allogeneic Adipose Tissue–Derived Mesenchymal Stem Cells Improves Myocardial Perfusion But Not Left Ventricle Function, in a Translational Model of Acute Myocardial Infarction Bobi, Joaquim Solanes, Núria Fernández‐Jiménez, Rodrigo Galán‐Arriola, Carlos Dantas, Ana Paula Fernández‐Friera, Leticia Gálvez‐Montón, Carolina Rigol‐Monzó, Elisabet Agüero, Jaume Ramírez, José Roqué, Mercè Bayés‐Genís, Antoni Sánchez‐González, Javier García‐Álvarez, Ana Sabaté, Manel Roura, Santiago Ibáñez, Borja Rigol, Montserrat J Am Heart Assoc Original Research BACKGROUND: Autologous adipose tissue–derived mesenchymal stem cells (ATMSCs) therapy is a promising strategy to improve post–myocardial infarction outcomes. In a porcine model of acute myocardial infarction, we studied the long‐term effects and the mechanisms involved in allogeneic ATMSCs administration on myocardial performance. METHODS AND RESULTS: Thirty‐eight pigs underwent 50 minutes of coronary occlusion; the study was completed in 33 pigs. After reperfusion, allogeneic ATMSCs or culture medium (vehicle) were intracoronarily administered. Follow‐ups were performed at short (2 days after acute myocardial infarction vehicle‐treated, n=10; ATMSCs‐treated, n=9) or long term (60 days after acute myocardial infarction vehicle‐treated, n=7; ATMSCs‐treated, n=7). At short term, infarcted myocardium analysis showed reduced apoptosis in the ATMSCs‐treated animals (48.6±6% versus 55.9±5.7% in vehicle; P=0.017); enhancement of the reparative process with up‐regulated vascular endothelial growth factor, granulocyte macrophage colony‐stimulating factor, and stromal‐derived factor‐1α gene expression; and increased M2 macrophages (67.2±10% versus 54.7±10.2% in vehicle; P=0.016). In long‐term groups, increase in myocardial perfusion at the anterior infarct border was observed both on day‐7 and day‐60 cardiac magnetic resonance studies in ATMSCs‐treated animals, compared to vehicle (87.9±28.7 versus 57.4±17.7 mL/min per gram at 7 days; P=0.034 and 99±22.6 versus 43.3±14.7 22.6 mL/min per gram at 60 days; P=0.0001, respectively). At day 60, higher vascular density was detected at the border zone in the ATMSCs‐treated animals (118±18 versus 92.4±24.3 vessels/mm(2) in vehicle; P=0.045). Cardiac magnetic resonance–measured left ventricular ejection fraction of left ventricular volumes was not different between groups at any time point. CONCLUSIONS: In this porcine acute myocardial infarction model, allogeneic ATMSCs‐based therapy was associated with increased cardioprotective and reparative mechanisms and with better cardiac magnetic resonance–measured perfusion. No effect on left ventricular volumes or ejection fraction was observed. John Wiley and Sons Inc. 2017-05-03 /pmc/articles/PMC5524109/ /pubmed/28468789 http://dx.doi.org/10.1161/JAHA.117.005771 Text en © 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Research Bobi, Joaquim Solanes, Núria Fernández‐Jiménez, Rodrigo Galán‐Arriola, Carlos Dantas, Ana Paula Fernández‐Friera, Leticia Gálvez‐Montón, Carolina Rigol‐Monzó, Elisabet Agüero, Jaume Ramírez, José Roqué, Mercè Bayés‐Genís, Antoni Sánchez‐González, Javier García‐Álvarez, Ana Sabaté, Manel Roura, Santiago Ibáñez, Borja Rigol, Montserrat Intracoronary Administration of Allogeneic Adipose Tissue–Derived Mesenchymal Stem Cells Improves Myocardial Perfusion But Not Left Ventricle Function, in a Translational Model of Acute Myocardial Infarction |
title | Intracoronary Administration of Allogeneic Adipose Tissue–Derived Mesenchymal Stem Cells Improves Myocardial Perfusion But Not Left Ventricle Function, in a Translational Model of Acute Myocardial Infarction |
title_full | Intracoronary Administration of Allogeneic Adipose Tissue–Derived Mesenchymal Stem Cells Improves Myocardial Perfusion But Not Left Ventricle Function, in a Translational Model of Acute Myocardial Infarction |
title_fullStr | Intracoronary Administration of Allogeneic Adipose Tissue–Derived Mesenchymal Stem Cells Improves Myocardial Perfusion But Not Left Ventricle Function, in a Translational Model of Acute Myocardial Infarction |
title_full_unstemmed | Intracoronary Administration of Allogeneic Adipose Tissue–Derived Mesenchymal Stem Cells Improves Myocardial Perfusion But Not Left Ventricle Function, in a Translational Model of Acute Myocardial Infarction |
title_short | Intracoronary Administration of Allogeneic Adipose Tissue–Derived Mesenchymal Stem Cells Improves Myocardial Perfusion But Not Left Ventricle Function, in a Translational Model of Acute Myocardial Infarction |
title_sort | intracoronary administration of allogeneic adipose tissue–derived mesenchymal stem cells improves myocardial perfusion but not left ventricle function, in a translational model of acute myocardial infarction |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524109/ https://www.ncbi.nlm.nih.gov/pubmed/28468789 http://dx.doi.org/10.1161/JAHA.117.005771 |
work_keys_str_mv | AT bobijoaquim intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction AT solanesnuria intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction AT fernandezjimenezrodrigo intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction AT galanarriolacarlos intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction AT dantasanapaula intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction AT fernandezfrieraleticia intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction AT galvezmontoncarolina intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction AT rigolmonzoelisabet intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction AT aguerojaume intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction AT ramirezjose intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction AT roquemerce intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction AT bayesgenisantoni intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction AT sanchezgonzalezjavier intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction AT garciaalvarezana intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction AT sabatemanel intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction AT rourasantiago intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction AT ibanezborja intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction AT rigolmontserrat intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction |